Gang
Wang
a,
Mo
Li
*b and
Peng
Zou
*acd
aAcademy for Advanced Interdisciplinary Studies, PKU-Tsinghua Center for Life Science, Peking University, Beijing 100871, China. E-mail: zoupeng@pku.edu.cn
bCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. E-mail: limo@hsc.pku.edu.cn
cCollege of Chemistry and Molecular Engineering, Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, 100871, China
dChinese Institute for Brain Research (CIBR), Beijing 102206, China
First published on 26th March 2025
Subcellular RNA localization is a conserved mechanism in eukaryotic cells and plays critical roles in diverse physiological processes including cell proliferation, differentiation, and embryo development. Nevertheless, the characterization of centrosome-localized mRNAs remains underexplored due to technical difficulties. In this study, we utilize APEX2-mediated proximity labeling to map the centrosome-proximal transcriptome, identifying DLGAP5 mRNA as a novel centrosome-localized transcript during mitosis. Using a combination of drug perturbation, truncation, deletion, and mutagenesis, we demonstrate that microtubule binding of nascent MBD1 polypeptides is required for centrosomal transport of DLGAP5 mRNA. Our data also reveal that mRNA targeting efficiency is tightly linked to the coding sequence (CDS) length. Thus, our study provides a transcriptomic resource for future investigation of centrosome-localized RNAs and sheds light on mechanisms underlying mRNA centrosomal localization.
Centrosomal mRNA localization might provide an efficient and rapid approach for transporting large centrosomal scaffold proteins to the centrosome and preventing ectopic PCM assembly.7–10 Disruption of centrosomal mRNA accumulation often results in dysfunctional centrosome and deficient ciliogenesis.7–9 For example, mistargeting Drosophila centrosomal mRNA Cen to the anterior cortex of the embryo impaired Cen protein localization to distal centrosomes, thus generating phenotypes similar to Cen loss. Ectopic Cen mRNA enrichment also interfered with local microtubule organization and spindle morphogenesis.8 These observations indicate that the local abundance of centrosomal mRNA is critical to maintain centrosome function. Therefore, identifying centrosome-localized RNAs and clarifying their targeting mechanisms could promote our understanding of their physiological roles.
Fluorescence microscopy and RNA sequencing are two major methods for assaying the subcellular localization of RNAs. The centrosomal localization of specific transcripts has been resolved in various biological contexts via in situ hybridization (ISH), including Drosophila,11,12Xenopus,13Ilyanassa,14Spisula,15 zebrafish,7 and HeLa cell lines.7,10 Genetically encoded RNA tags, such as MS2/MCP, enabled the visualization of ASPM or NUMA1 mRNA to the centrosome in live cells.10 Besides imaging-based methods, transcriptome-wide analysis of purified mitotic spindles further expanded the list of spindle-associated RNAs.16,17 However, due to challenges associated with purifying the centrosome, biochemical fractionation often requires pre-stabilizing the mitotic spindle with taxol to facilitate its precipitation, which limits its applications.16,17 Thus, high-throughput sequencing techniques currently remain under-utilized in discovering centrosome-localized transcripts.
Enzyme-mediated proximity labeling (PL) methods have emerged as a powerful tool for deciphering molecular interactions.18,19 These methods utilize promiscuous labeling enzymes, such as APEX2, to generate reactive intermediates to label neighboring biomolecules including proteins and RNAs.20–22 While the high spatial specificity of APEX2 has enabled the proteomic mapping of centrosomal components,23 PL methods have not been applied to profile the centrosomal transcriptome. We have recently developed the MERR APEX-seq method with improved RNA detection sensitivity through metabolic incorporation of electron-rich nucleosides (s6G or s4U).24 Herein, we applied MERR APEX-seq to decipher the centrosome-proximal transcriptome and identified DLGAP5 as a centrosome-localized mRNA in the mitotic phase. We further demonstrated that the targeting of DLGAP5 depends on the microtubule cytoskeleton and the ribosomal translation of microtubule binding domain 1 (MBD1) polypeptides.
Next, we evaluated the spatial specificity of MERR APEX-seq labeling in APEX2-PCNT-EGFP and APEX2-NES cell lines via immunofluorescence imaging. Both cell lines were pretreated with s6G for 5 hours before incubation with 0.5 mM biotin–phenol (BP) for 30 min, and the biotinylation reaction was triggered by the addition of hydrogen peroxide (H2O2). After 1 min H2O2 treatment, the reaction was quenched by a cocktail of free radical scavengers and peroxidase inhibitors, including sodium ascorbate, sodium azide, and Trolox (Fig. 1B). Thereafter, the cells were either fixed for imaging or lysed for RNA-seq analysis. Immunofluorescence imaging revealed that the BP labeling signal co-localized with APEX2 expression in APEX2-PCNT-EGFP cell lines (Fig. 1C). In the negative control sample omitting the BP probe, only the signal from endogenous biotinylated proteins was observed. In the APEX2-NES cell line, the biotinylation signal mainly distributed throughout the cytosol, with a negligible background in the control (Fig. S1, ESI†).
To obtain the transcriptomes specifically labeled by APEX2-PCNT-EGFP or APEX2-NES fusion proteins, the total RNAs were extracted from labeled cells, digested by DNase I to remove residual DNA, and purified by streptavidin-coated magnetic beads. Following isolation of poly(A)+ RNA, biotinylated RNAs were subjected to fragmentation for cDNA library construction and high-throughput sequencing (Fig. 1B). We performed three independent biological replicate experiments with both cell lines. Enrichment of biotinylated RNAs from the APEX2-PCNT-EGFP and APEX2-NES cell lines was reproducible as revealed by high Pearson's correlation coefficients (>0.94) (Fig. S2A and B, ESI†).
To identify centrosome-localized transcripts, we performed DESeq226 analysis comparing the abundance of RNAs enriched from the centrosome-localized APEX2 sample (enrich) versus two separate negative controls: (1) RNAs from unlabeled samples omitting BP (control); or (2) RNAs labeled by cytosol-localized APEX2 to remove the background signals arising from free radical diffusion. Furthermore, to normalize gene expression levels, RNAs with significantly higher abundance (log2Fold change >1 and an FDR-adjusted p-value < 0.05) in the APEX2-PCNT-EGFP cell line were removed from the second dataset (see Methods and Data S1, ESI†). The above analysis yielded 112 transcripts, among which 15 mRNAs encode known centrosome- or mitosis-associated proteins (Fig. 1D and E). The percentage (13%) of transcripts with centrosome-associated GOCC annotations in our dataset was about two-fold of that (7%) in mRNAs expressed in the APEX2-PCNT-EGFP cell line (Fig. S3, ESI†). NIN, a previously reported centrosome-localized transcript,9,10 was included in our dataset (Fig. 1E and Table S3, ESI†). We confirmed its centrosomal enrichment during interphase via smFISH, which was consistent with previous studies.9,10 (Fig. S4, ESI†). Other known centrosome-targeted mRNAs (ASPM, PCNT, NUMA1, etc.) were not identified as enriched transcripts in our proximity labeling experiments (Table S3, ESI†).
The DLGAP5/HURP protein encoded by DLGAP5 mRNA co-localizes with the mitotic spindle when cells enter into mitosis. It is a Ran-Importin β-regulated protein that stabilizes the kinetochore microtubules in the vicinity of chromosomes.27–31 Consistent with the previous study,31 smFISH imaging revealed that the level of DLGAP5 expression was more variable across cells during interphase than during the mitotic phase (Fig. S6, ESI†). smFISH imaging also confirmed the centrosomal targeting of DLGAP5 mRNA, and revealed that its subcellular localization was tightly linked to the cell cycle. During interphase and early mitosis, DLGAP5 mRNA was randomly distributed in the cytoplasm. When cells enter prometaphase and metaphase, prominent centrosomal localization of DLGAP5 mRNA was observed. As the cell cycle progresses into the late mitotic stages, DLGAP5 mRNA became gradually diffusive throughout the cell (Fig. 2A and B).
We next examined whether the centrosomal localization of DLGAP5 mRNA during mitosis is conserved among other cell types and species. To this end, we investigated the localization of DLGAP5 mRNA in five human cancer cell lines: HeLa, MCF-7, MDA-MB-231, U-2 OS, and SH-SY5Y. Remarkably, except for SH-SY5Y cells, we observed centrosomal or spindle pole localization of DLGAP5 mRNA in all other cell lines during mitosis (Fig. 2C). Additionally, we explored the subcellular localization of Dlgap5 mRNA, the mouse orthologs of the human DLGAP5 mRNA, in the mouse Neuro-2a cell line and observed the centrosomal targeting of Dlgap5 mRNA in metaphase (Fig. 2C). Together, these observations demonstrate that the centrosomal localization of DLGAP5 mRNA is evolutionarily conserved, suggesting a common mechanism of centrosomal mRNA targeting in both human and mouse cells.
Active transport of mRNPs usually involves cytoskeleton networks.35,36 Centrosomes localize at the minus-end of microtubules and function as the main microtubule-organizing centers.1 Thus, we next examined whether the localization of DLGAP5 mRNA relies on the microtubules. When HEK293T cells were treated for 20 min with nocodazole, an inhibitor of microtubule polymerization, the microtubule cytoskeleton was disintegrated while the centrosome remained intact (Fig. S7, ESI†). Consistent with the role of the cytoskeleton in mRNA localization, nocodazole significantly disrupted the centrosomal enrichment of DLGAP5 mRNA (Fig. 3A and B).
Taken together, our data suggested that the DLGAP5 mRNA localization depends on the intact RNC and microtubule cytoskeleton in HEK293T cells. We next asked whether the localization mechanism is conserved in other cell types. For this purpose, we repeated puromycin, cycloheximide, and nocodazole perturbation in HeLa cells. Consistent with our observation in HEK293T cells, puromycin and nocodazole, but not cycloheximide, significantly affected the centrosomal accumulation of DLGAP5 mRNA during mitosis (Fig. S8, ESI†). These data indicated that DLGAP5 mRNA is co-translationally targeted to the centrosome via cytoskeletons in HEK293T and HeLa cells.
To further elucidate how DLGAP5 mRNA was transported to the centrosomes, we designed the following EGFP reporter mRNAs to examine which region of DLGAP5 mRNA was sufficient and necessary for its localization. We started by testing whether the untranslated regions (UTRs) of DLGAP5 mRNA is capable of targeting EGFP to centrosomes. We fused the EGFP ORF to either the 5′UTR of DLGAP5 (DLGAP5 5′UTR-EGFP) or the 3′UTR of DLGAP5 (EGFP-DLGAP5 3′UTR). When these reporters were transiently expressed in HeLa cells and detected using smFISH probes against the EGFP ORF sequence, we did not observe enrichment of EGFP mRNAs around the centrosomes in mitotic cells (Fig. 3C and D). When fusing EGFP ORF to the DLGAP5 CDS (EGFP-DLGAP5 CDS), smFISH imaging of the reporter showed substantial localization of the fusion mRNA to the centrosomes in metaphase, which was similar to endogenous DLGAP5 mRNA. Moreover, consistent with the previous study, the EGFP-DLGAP5 fusion proteins co-localized with the mitotic spindle (Fig. 3C and D).29,37 As a negative control, the mRNAs of EGFP ORF alone were randomly distributed throughout the cytoplasm in HeLa cells (Fig. 3C and D). Together, the above data demonstrated that the UTRs of DLGAP5 mRNA are dispensable for its centrosomal localization.
Given our previous observation that active protein translation is required for efficient DLGAP5 mRNA localization to the centrosomes, we next asked whether the DLGAP5 CDS sequence alone or its translation product mediates the centrosomal localization of its mRNA. By inserting a stop codon (UAG) between the EGFP ORF and DLGAP5 CDS, we created a reporter mRNA (EGFP-stop-DLGAP5 CDS) that differs from the previous EGFP-DLGAP5 CDS reporter by only the translation of the DLGAP5 CDS. Immuno-smFISH imaging revealed that the introduction of the stop codon abolished both the spindle localization of the EGFP protein and the centrosomal targeting of reporter mRNA (Fig. 3C and D). Taken together, we concluded that the translation of DLGAP5 CDS is both sufficient and necessary for trafficking its transcript to the centrosome during mitosis.
Based on the DLGAP5 protein structure, we designed two panels of EGFP reporters to identify the domain involved in its mRNA localization. The first panel contains C-terminally truncated DLGAP5 CDS with varying lengths, which aims for identifying the minimal CDS fragment that is sufficient to localize the reporter mRNA. (Fig. 4A). smFISH imaging analysis reveals that fusions with DLGAP5 CDS encoding the first 624, 425, or 308 aa are sufficient to localize the reporter mRNA to the centrosome. In contrast, fusion with only the first 231 aa of the protein failed to achieve mRNA targeting to the centrosome (Fig. 4A and B). These observations strongly suggest that the first 308 aa in the DLGAP5 polypeptide, which include both MBD1/2 domains, might mediate DLGAP5 mRNA localization, and the segment between 232 and 308 aa likely plays a key role in this process.
In the second panel, several CDS fragments are individually deleted from the full-length DLGAP5 CDS, allowing the examination of peptide segments that are necessary for the centrosomal mRNA targeting (Fig. 4A). Consistent with our results from the above truncation analysis, deletion of amino acids after the site 308 (Δ309–425 or Δ426–624) from the full-length CDS had minimal effects on the centrosomal enrichment of the reporter mRNA (Fig. 4A and C). It was expected that deletion of the peptide segment between amino acid 232 and 308 (Δ232–308) should abolish the DLGAP5 mRNA localization to the centrosomes. However, no significant effect was observed in this deletion on DLGAP5 mRNA targeting (Fig. 4A and C). As the deletion sites moved further to the N-terminus, our data showed that both the segments of 2–69 aa (i.e. MBD2 domain) and 175–231 aa are dispensable for the mRNA targeting (Fig. 4A and C). However, removal of the MBD1 domain (Δ65–174) led to almost complete abolishment of the centrosomal mRNA targeting (Fig. 4A and D). Taken together, the above data demonstrated that MBD1 domain is necessary but not sufficient to drive DLGAP5 mRNA targeting to the centrosome.
We next sought to determine whether the interaction between MBD1 and microtubules is involved in DLGAP5 mRNA localization to the centrosome. The binding of the DLGAP5 protein to the microtubules has been shown to regulate its localization, degradation, and function. While MBD1 constitutively binds to microtubules with high affinity, the interaction between MBD2 and microtubules is weaker and inhibited by Importin β.30,39,42 We replaced six critical positively charged residues in MBD1 (K105, K107, R110, K112, K114, and R115) with alanine to ablate its microtubule binding activity.39 Introducing these mutations into full-length CDS (MBD1*) significantly disrupts the localization of the reporter mRNA and EGFP fusion protein (Fig. 4A and D). Consistent with the above observation, removal of the peptide segment that harbors the above critical residues (Δ90–120) also abolishes centrosomal mRNA targeting (Fig. 4A and D). Together, these results confirm that the microtubule binding activity of MBD1 is critical for the centrosomal localization of DLGAP5 mRNA.
We then created three reporter mRNAs containing the CDS of MBD1 fused to the N-terminus of EGFP (MBD1-EGFP, 355 aa), tdGFP (MBD1-tdGFP, 603 aa), or tdGFP-Halotag (MBD1-tdGFP-HT, 907 aa) to carefully verify our hypothesis. Among these reporters, the longest fusion MBD1-tdGFP-HT exhibited the strongest centrosomal localization of the EGFP mRNA reporter (Fig. 5A and B). Replacing the MBD1 domain with the microtubule-binding-deficient MBD1* abolished centrosomal enrichment of reporter mRNA, further confirming the vital role of the microtubule binding activity of MBD1 (Fig. 5A and B). When the CDS sequence is shuffled with the MBD1 domain moved further to the C-terminus (tdGFP-MBD1-HT and tdGFP-HT-MBD1), the centrosomal localization of reporter EGFP mRNA is also significantly reduced (Fig. 5A and B). Taken together, we concluded that the centrosomal targeting of DLGAP mRNA requires the translation of its CDS encoding MBD1 along with a long peptide (approximately 600 aa) at the C-terminus.
Finally, we sought to understand why the CDS length is linked to mRNA localization efficiency. Generally, longer CDS means that the ribosomes stay associated with mRNA for a longer time. Nevertheless, in our reporter assay, cells transiently expressing EGFP reporters were treated with cycloheximide prior to fixation, resulting in the freezing of ribosomes on the mRNAs. Thus, the longer engagement of ribosomes with mRNAs might not be a main contributor. Alternatively, we supposed that the nascent MBD1 peptide dwell time and MBD1 peptide concentration might play vital roles in mRNA localization. For instance, when MBD1 is positioned at the N-terminus of the construct, increasing CDS length simultaneously prolongs the dwell time of nascent MBD1 peptides on the mRNA and elevates the number of translating ribosomes. Both factors increase the local concentration of nascent MBD1 peptides in the polysome, synergistically enhancing centrosomally targeting of reporter mRNA.
To verify our hypothesis, we fused tandem MBD1 to the N-terminus of EGFP, thus producing tandem nascent MBD1 polypeptides. The reporter mRNA transcribed from this construct localized to the centrosome. However, when replacing the second MBD1 with MBD1*, the centrosomal accumulation of reporter mRNA was disrupted without affecting the spindle localization of EGFP fusion proteins (Fig. 5B and C). The distinct localization of the above two reporters with the same CDS length further implied that the residence time of ribosomes on the mRNAs may not play key roles. Taken together, these observations supported the role of the local concentration of nascent MBD1 polypeptides in promoting the centrosomal targeting of DLGAP5.
We further identified microtubule interactions with nascent MBD1 polypeptides as the mediator for the centrosomal localization of DLGAP5 mRNA (Fig. 6). Interestingly, several centrosome-localized mRNAs have been reported to encode proteins that can directly bind microtubules (e.g. ASPM, NUMA1, HMMR, and CEP350) or the motor protein dynein (e.g. NIN, BICD2, CCDC88C, and NUMA1).45–49 It is likely that the microtubule- or dynein-interacting nascent polypeptides might participate in the transport of their mRNA. This hypothesis could be tested using reporter mRNA assays in future studies.
![]() | ||
Fig. 6 Proposed localization mechanism for DLGAP5 mRNA. Created in BioRender. https://BioRender.com/omwo3kq. |
An intriguing finding in this study is the dependence of DLGAP5 mRNA centrosomal targeting on its CDS length, the dwell time and copy number of the MBD1 domain, all of which likely affect the local concentration of nascent MBD1 polypeptides on the polysomes. Increasing the CDS length or shifting MBD1 to the N-terminus drives the centrosomal targeting of the reporter mRNA. Indeed, emerging evidence links the transcript length to subcellular RNA localization. For instance, shorter transcripts are enriched in nuclear speckles, while longer transcripts associate with the nuclear lamina or G1-phase processing bodies.50,51 However, whether the CDS length influences co-translational mRNA targeting via nascent polypeptide quantities remains unexplored in other subcellular compartments. Furthermore, MBD1 contains a conserved coiled-coil motif (90–120 aa), which might undergo liquid–liquid phase separation (LLPS) in a concentration manner.52 A recent study revealed that PCNT undergoes phase separation through its coiled-coils and low-complexity regions during co-translational transport of its mRNA to the centrosome.53 Whether similar LLPS occurs during the centrosomal targeting of DLGAP5 mRNA warrants further investigation.
While we have identified the nascent MBD1 domain as a necessary element for DLGAP5 mRNA localization, several questions remain regarding the localization mechanism. On the one hand, the transport machinery responsible for centrosomal targeting and interacting partners of MBD1 polypeptides remain unknown. Dynein, which transports cargoes to the microtubule minus-end, is implicated in the centrosomal localization of PCNT and NIN mRNA.7,9 However, our preliminary experiments showed that the inhibition of dynein had little effect on DLGAP5 mRNA localization (data not shown). Thus, whether dynein is involved in DLGAP5 mRNA transport is still an open question. On the other hand, centrosomal targeting of DLGAP5 mRNA is tightly linked to the cell cycle, but regulators related to its cell cycle dynamics remain elusive. Phosphorylation of the C-terminus of the DLGAP5 protein by Aurora A was found to control its microtubule binding activity of the N-terminus through the autoinhibition mechanism.37 Thus, cell-cycle-regulated post-translational modifications in the nascent DLGAP5 polypeptide might play a role in the mRNA localization. Moreover, mitosis-specific translation regulators might be involved in the localization process.
Subcellular RNA localization generally enables precise spatio-temporal control of gene expression.35,36 The biological significance of DLGAP5 mRNA localized to the centrosome is unresolved in this study. Considering that the local abundance of the DLGAP5 protein on the mitotic spindle is related to spindle stability and mitosis progression, its mRNA localization might be an ideal approach to finely tune the local protein dosage.28,30,42 Approaches including transcript-specific translation inhibition and the ectopic targeting of aptamer-tagged mRNAs should help us unearth the physiological role of DLGAP5 mRNA localization.
Primary antibodies used in this study are listed as below: mouse V5-tag monoclonal antibody (3C8) (1:
800, Biodragon, B1005), rabbit anti-CEP152 antibody (1
:
200, Sigma-Aldrich, HPA039408), rabbit anti-CDK5RAP2 antibody (1
:
200, Sigma-Aldrich, HPA046529), mouse monoclonal anti-γ-tubulin antibody (1
:
1000, Sigma-Aldrich, T5326), rabbit anti-PCNT antibody (1
:
500, abcam, ab4448), and the rat anti-α-tubulin monoclonal antibody (YL1/2) (1
:
500, Invitrogen, MA180017). Secondary antibodies against the above primary antibodies were: Alexa Fluor 647-conjugated anti-mouse goat IgG (H + L) (1
:
1000, Invitrogen, A-21236), Alexa Fluor 568-conjugated anti-rabbit goat IgG (H + L) (1
:
1000, Invitrogen, A-11036), and Alexa Fluor 488-conjugated anti-rat goat IgG (H + L) (1
:
1000, Invitrogen, A-11006). Alexa Fluor 568-conjugated Streptavidin (1
:
1000, Invitrogen, S11226) was utilized to counterstain biotinylation.
The enrichment of biotinylated RNAs was performed as previously reported.54 Briefly, Dynabeads MyOne Streptavidin C1 beads (Invitrogen, 65002), using 10 μL beads per 50 μg of RNA, were washed three times with a bead washing buffer (5 mM Tris, pH7.5, 1 M NaCl, 0.5 mM EDTA, 0.1% v/v Tween-20), followed by twice in Solution A (0.1 M NaOH and 0.05 M NaCl) and once in Solution B (0.1 M NaCl). The beads were then blocked with a bead washing buffer supplemented with 1 mg mL−1 BSA and 1 mg mL−1 yeast tRNA (Invitrogen, 15401011) on the vortex at room temperature for two hours. Then, the beads were washed three times with a bead washing buffer, followed by incubation with purified RNAs in a bead washing buffer supplemented with 1 U μL−1 RiboLock RNase Inhibitor at room temperature for 40–50 min with thorough mixing. The biotinylated RNA-bound beads were next washed three times with a bead washing buffer, twice with urea buffer (4 M urea and 0.1% SDS in PBS), and twice with PBS at room temperature to remove non-specific absorption. Finally, biotinylated RNAs were eluted with RNA elution buffer (95% formamide, 10 mM EDTA, and 1.5 mM D-biotin) at 50 °C for 5 min, followed by 90 °C for 5 min on a shaker. The eluted RNAs were purified with TRIzol reagent as per manufacturer's instructions. 20 μg glycogen was added to the aqueous phase to assist precipitation before performing isopropanol precipitation. The purified biotinylated RNAs were dissolved in 20 μL RNase-free water and termed as the enrich sample for labeling samples and control sample for the negative control omitting the BP probe. Before the library construction of input, enrich, and control samples, we generally performed reverse transcription and qRT-PCR to evaluate the enrichment efficiency of biotinylated RNAs.
The smFISH samples were prepared according to a previous report.56 Briefly, cells expressing EGFP reporters or treated with drugs were fixed with 3.2% paraformaldehyde (PFA) dissolved in PBSM (1 mM MgCl2 in PBS) at room temperature for 10 min. The fixed cells were then washed with pre-chilled PBSM supplemented with 10 mM glycine three times, followed by permeabilization with PBSM containing the 0.1% Triton X-100 and 2 mM vanadyl ribonucleoside complex (VRC) on ice for 20 min. After washing with PBSM twice, cells were incubated with prehyb-30 buffer (30% formamide, 2× SSC) at room temperature for 10 min with gentle shaking. Next, the cells were stained with the primary probe hybridization buffer (10% dextran sulfate, 30% formamide, 2× SSC, 2 mM VRC, 10 μg mL−1 salmon sperm DNA, 10 μg mL−1E. coli tRNA, 10 μg mL−1 BSA, and a 200 ng primary probe mix) at 37 °C overnight. After primary probe hybridization, cells were washed with prehyb-30 buffer at 37 °C three times, followed by washing with 2× SSC buffer once at room temperature. Then, cells were fixed with 1% PFA dissolved in PBSM at room temperature for 5 min. After two times’ washing, cells were incubated with prehyb-10 buffer (10% formamide, 2× SSC) at 37 °C for 10 min. Cells were hybridized with fluorescent Flap X or Flap Y probes in a secondary probe hybridization buffer (10% dextran sulfate, 10% formamide, 2× SSC, 2 mM VRC, 10 μg mL−1 salmon sperm DNA, 10 μg mL−1E. coli tRNA, 10 μg mL−1 BSA, and 10 ng FLAP probes) at 37 °C for at least three hours. Stained cells were then washed twice with prehyb-10 buffer at 37 °C, followed by a final wash in 2× SSC buffer.
For smFISH imaging in APEX2-PCNT-EGFP cells, the cells were stained with DAPI diluted in PBSM at room temperature for 10 min and mounted in a Fluoromount-G anti-fade mounting medium (SouthernBiotech, 0100-35) for following imaging. For smFISH imaging in wild-type HEK293T or HeLa cell lines, the endogenous PCNT protein was immunostained to mark the centrosome. Following washing in 2× SSC buffer, the cells were washed twice with PBSM, and incubated with the anti-PCNT antibody diluted in PBSM (1:
500) at 4 °C overnight. After three times washing with PBSM, the cells were incubated with the Alexa Fluor 568-conjugated goat anti-rabbit secondary antibody at room temperature for one hour. After washing with PBSM and staining with DAPI, cells were mounted for the following imaging.
All the fluorescence images were analyzed using Fiji software.57 Mitotic cells were identified based on high DNA compaction and the existence of two pairs of centrioles manually. Quantitative analysis of smFISH images were performed using FISH-quant according to the manufacturer's manual.55,58 Briefly, the intensity of the DAPI channel was used to identify the nucleus and membrane boundary manually. For drug perturbation assays and EGFP reporter assays, only prometaphase, metaphase, and anaphase (estimated via DAPI staining) cells were chosen for following FISH-quant analysis. mRNA spots were detected from the smFISH channel and centrosomes from the anti-PCNT channel. mRNA spots were detected and counted using FISH-quant. For EGFP reporter assays, only cells with less than 500 spots per cell were subjected to co-localization analysis (Fig. S10B, S11, S12, and S13, ESI†). The colocalization of mRNA spots and centrosomes were analyzed using an FQ_DualColor module. The maximum allowed distance between the two spots was set as 2 μm according to a previous study.10 In other words, RNAs, less than 2 μm away from the nearest centrosome, were identified as centrosome-proximal RNAs. Significance of the proportion of centrosome-proximal mRNAs was evaluated with a two-sided Mann–Whitney test in this study.
To identify centrosome-localized RNAs, differential expression analysis between the labeled samples and control samples was carried out using DESeq2.26 The arbitrary cutoff for DESeq2 analysis was log2Fold change > 1, FDR-adjusted p-value < 0.05, and baseMean > 100. When applying the above cutoff to PCNT_enrich vs. PCNT_control analysis, 1903 RNAs were significantly enriched. For PCNT_enrich vs. NES_enrich analysis, 1595 RNAs were significantly enriched. Among these 1595 RNAs, 773 RNAs have significantly higher expression levels (log2Fold change >1 and FDR-adjusted p-value < 0.05) in the APEX2-PCNT-EGFP cell line. Thus, 822 RNAs were more preferentially labeled by centrosome-localized APEX2 compared to cytosol-localized APEX2. Overlapping the above 1903 and 822 RNAs generated the final dataset containing 112 RNAs. The list of these 112 RNAs is provided in Data S1 (ESI†). Centrosome-associated proteins were defined as proteins containing centrosome- or mitosis-related GOCC terms, i.e. “centrosome”, “centriole”, “pericentriolar material”, “microtubule”, “equatorial cell cortex”, “midbody”, “spindle”, “mitotic spindle”, “cell division site part”, “kinetochore”, “condensed chromosome”, “centromere”, and “telomere”.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d4cb00155a |
This journal is © The Royal Society of Chemistry 2025 |